↓ Skip to main content

Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives

Overview of attention for article published in Clinical and Translational Oncology, November 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
41 Mendeley
Title
Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives
Published in
Clinical and Translational Oncology, November 2018
DOI 10.1007/s12094-018-1975-4
Pubmed ID
Authors

T. Mocan, Z. Sparchez, R. Craciun, C. N. Bora, D. C. Leucuta

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 24%
Student > Ph. D. Student 6 15%
Student > Bachelor 5 12%
Student > Master 3 7%
Student > Doctoral Student 3 7%
Other 3 7%
Unknown 11 27%
Readers by discipline Count As %
Medicine and Dentistry 13 32%
Biochemistry, Genetics and Molecular Biology 4 10%
Agricultural and Biological Sciences 3 7%
Immunology and Microbiology 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 0 0%
Unknown 18 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 December 2019.
All research outputs
#14,144,128
of 23,109,468 outputs
Outputs from Clinical and Translational Oncology
#582
of 1,326 outputs
Outputs of similar age
#187,969
of 351,023 outputs
Outputs of similar age from Clinical and Translational Oncology
#15
of 36 outputs
Altmetric has tracked 23,109,468 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,326 research outputs from this source. They receive a mean Attention Score of 3.7. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,023 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.